Vyteris and Zealand Pharma Announce Agreement on Active Transdermal Patch
Vyteris and Zealand Pharma Announce Agreement on Active Transdermal Patch for Peptide Drugs (Marketwire)
Collaboration Aimed at Increasing Delivery Options for Peptides
« FDA Warns Consumers, Food Service Operators, and Retailers to Avoid | Main | FDA Approves Generic Topamax to Prevent Seizures The U.S. Food »